Jim Tananbaum is the leader behind the success of Foresite Capital. He is the founder and the CEO of the company. He has also involved the formation of GelTex Pharmaceuticals (NASDAQ: GENZ) Theravance, Inc. The companies are some of the best firms in pharmaceuticals in the region. Other companies that he co-founded is Prospect Venture Partners II and III and Sierra Ventures. Jim Tananbaum is a successful investor with over 21 healthcare enterprises. Some of the healthcare companies that he owns are Amira Pharmaceuticals and Amerigroup.
Jim declared Dr. Molly He as the venture partner of Foresite Capital. He served as the senior director at Illumina before joining the Foresite Capital. Her experience and management skills in Pharmaceuticals was earned in 15 years. She also has a lot of experience in genomic research and development. Dr. Molly He is recognized by Jim for his contribution and honor as a scientific researcher, reports Wired.com. Dr. He has specialized in the research of next-generation sequencing. Her knowledge and research skills in genomics and drug development are of great benefit to Foresite Capital. She also has outstanding leadership experience which fundamental in the growth of the company.
Dr. He is recognized for her involvement in the expansion of Illumina to global reagent innovation. She pursued biochemistry at Nankai University and graduated with Bachelor’s degree in the course. He enrolled at the University of California to research protein biophysics, and she was awarded a Ph.D. from the same university. Foresite Capital is one of the largest companies leading in innovative and exciting healthcare. The company targets public and private sectors.
Jim Tananbaum’s success in investment is attributed to 25 Years of experience in various leadership positions. He served at GeiTex Pharmaceuticals and Theravance, and he received promotions to work at various executive positions in the companies. He was selected to serve at Harvard-MIT HST Program as a member of advisory board’s committees. He was also appointed to serve on the advisory board’s committees at Yale School of Engineering. His experience in healthcare, management, and innovation has enabled him to contribute productively to the boards.
The success of Jim Tananbaum is the rich academic qualifications which he has attained. He joined Harvard Medical School and graduated with M.D. He was awarded a BS, and a B.S.E.E by Yale University. Tananbaum enrolled Harvard Business School and pursued MBA. Inc42 reports Forbes listed Tananbaum as position 52 in its Midas List for 2017.